Digital Pharma

2018年9月19-20日 • シンガポール、One Farrer Hotel & Spa

概要

デジタル革命は、さまざまな事業分野で破壊的な変化を起こしつつあり、製薬業界も例外ではありません。Digital Pharma Summitでは、世界の製薬業界における技術面の展望、新たなトレンド、革新的な導入戦略、投資、デジタル化プロジェクトのケーススタディなど、さまざまなトピックをめぐって議論が展開されます。

IBC主催第5回PharmaCon Asia 2018の一翼を担うこのサミットは、アジア地域の製薬業界に従事している専門職が一堂に会する重要イベントとなっています。会期中は、臨床試験、市場参入、製薬業界のデジタル化、法令遵守の原則などのトピックが取り上げられ、医薬品開発と商業化に関連するバリューチェーンのあらゆる領域に光が当てられます。

この学会のみどころ

  • 製薬業界のデジタル化をテーマにしたアジア地域で唯一のイベントであり、デジタルトランスフォーメーションの影響を受けているさまざまな企業のケーススタディが紹介されます。
  • アジアのみならず世界各地域でデジタルトランスフォーメーションに携わっている専門家と人脈を構築し、製薬業界についての見解を聞くことができます。
  • 技術面の展望や製薬業界に対する影響などが明らかにされます。
  • 技術面の最新トレンドやデジタル技術の進歩にスポットライトが当てられます。
  • 製薬業界のエコシステムにおける新たなビジネスモデルや革新的な提携についての分析が示されます。
  • デジタル化の面で注目を集めている製薬会社の最新情報が紹介されます。

同時併催されるイベント

Accelerating Clinical Trials in Asia >>
Pharma Regulatory Affairs Summit >>
Pharma Market Access and Pricing Summit Asia >>

 

アジェンダ

8:00 am

Registration and Networking Session

PHARMACON ASIA OPENING PLENARY SESSION

9:00 am

Addressing on skilled talent, strong manufacturing capabilities and thriving research ecosystem in pharmaceutical firms to set up to serve patients and connect with the growing Asian market

9:30 am

[Industry Address] Integrating Silicon with Drugs: Pushing the Boundaries of Pharma Manufacturing with Digital Medicines

Nik Leist, Senior Director, Ingestible Sensor Manufacturing/Site Leader, Proteus Digital Health, USA

10:40 am

Morning Networking and Refreshment Break

DIGITAL PHARMA SUMMIT COMMENCES

11:10 am

Digital Pharma Chairman's Opening Remarks

TRENDS IN DIGITALISATION

11:15 am

CIO Interview: Progressing Digital Transformation in Pharma

Bruce Shi, Chief Information Officer, Asia, Sanofi, Singapore

11:45 am

  • Snapshots on tech trends that are gaining traction
  • Where are digital investments going?
  • How can pharmaceutical companies leverage them in compliance with stringent regulations
  • New regulatory framework to build trusted algorithms

CIO Interview: Progressing Digital Transformation in Pharma

Bruce Shi, Chief Information Officer, Asia, Sanofi, Singapore

REDEFINING PHARMA - CONSUMER INTERACTIONS

1:00 pm

Networking Lunch

2:00 pm

  • Importance of staying engaged with consumers/patients
  • Preparing for disruption
  • Why MNCs are at risk of disruptions

2:30 pm

Developing Innovative Technological Solutions to Improve Patient Outcomes

Aaron Tian, Head of Neuroscience Patient Innovation, UCB, China

3:00 pm

Tech Showcase: Strategies to Seamlessly Integrated and Personalised Customer Experience and Patients Outcomes Online and Offline

3:30 pm

Afternoon Networking

4:00 pm

  • How can digitalisation and connected world play the part in monitoring better patient outcomes, drug performance and market dynamics of approved drugs?
  • How is the deployment of smartphone seen as 'an access to global knowledge powered by AI in anyone's hand'
  • How can it trigger a revolution in pharmacovigilance and risk minimisation?
  • Case studies to elaborate on the need for a versatile app to enforce educational risk minimization

4:30 pm

  • The rise of apps as medical devices
  • The convergence between tech and pharma
  • How artificial intelligence will make healthcare more efficient

REGIONAL TRENDS IN PHARMA 4.0

5:00 pm

  • 100 Experiments (100E) programme
  • How the Pharma industry is benefiting
  • Use cases of how AI is applied in the Pharma industry

5:30 pm

  • Examining the current impact of digitalisation in the Asian Pharma sector
  • What touch points will have most influence
  • How is Pharma – HCP - Patient engagement going to change
  • Pharma and Consumer interface evolution
  • What is needed to give Pharma a digital boost

6:00 pm

End of Conference Day 1, followed by networking cocktails

8:55 am

Morning Coffee

PHARMA - HCP RELATIONSHIPS

9:00 am

Digitalising Pharma - HCP Engagement: Challenges, Opportunities and Benefits

Julie Olszewski, Executive Director, MSD Global Innovation Hub, MSD, Singapore

9:30 am

  • Patient journey and their experience with medication is changing with the increasing pervasiveness of digital and mobile communication platform
  • Addressing technological advancement such as cloud, IoT, data analytics and AI
  • Medical doctors' experience on rapid change and transformation from the impact of technology
  • How can patients, doctors and pharma find the convergence and success in digital solutions and what good (experience) looks like?

BEYOND THE PILL

10:00 am

Digital Pharma and Precision Medicine in the Age of Data Science, Machine Learning and Real Time Analytics

Yaron Turpaz, Chief Data & Technology Officer, Managing Director, Global Gene Corp, Singapore

10:30 am

Morning Networking and Refreshment Break

11:00 am

  • Trends of digital innovations in Pharma & Healthcare
  • Challenges in adapting digitalization in these fields
  • How digitalization will help to create value chain for the patients

11:30 am

Use & Perception of Scientific Medical Reprints and Opportunities in Digital Marketing

Amit Singh, Director - Pharma Business, Elsevier, India

12:00 pm

  • Overview of emerging trends in medical technologies, and extrapolation to future business opportunities for digital pharma
  • Direct-to-consumer distribution and supply chain optimisation

12:30 pm

Networking Lunch

1:30 pm

Case Study: Preventing the Risk of Cardiovascular Disease via a Doctor - Patient - Consumer Digital Platform

Dr. Peter Ting, Co-Founder, Cardiatrics, Senior Consultant Cardiologist, Gleneagles and Mt. Elizabeth Hospital, Singapore

2:00 pm

The Impact of Technology in Reshaping the Thinking of Pharma Leaders - Transformation, Investments, Business Strategies

Tamsin Greulich-Smith, Chief, Smart Health Leadership Centre, Institute of Systems Science, National University of Singapore, Singapore

ENABLING DIGITALISATION

2:30 pm

  • Starting out on analytics journeys - common starting points that set you up for failure
  • Problems with process - 'right governance wrong place' processes that set analytics up to fail
  • Metric malfunction - how managing an analytics department can look right on paper but still be worthless
  • 3 big ideas that will help you avoid these pitfalls and get real value from analytics

3:00 pm

  • Will this be a barrier for pharma companies to digitally transform?
  • How can traditional practices be seamlessly transform to accommodate to the digital age's needs?

3:30 pm

Afternoon Networking

CLOSING PLENARY SESSION

5:00 pm

Chairperson's Summary of the Day and End of Conference

* 不測の事態により、事前の予告なしにプログラムが変更される場合があります。

講演者

Ho Weng Si

Director, Biomedical Sciences Group, Economic Development Board, Singapore

Nik Leist

Senior Director, Ingestible Sensor Manufacturing/Site Leader, Proteus Digital Health, USA

Enver Erkan

Country Manager, Pfizer Singapore

Alexis Serlin

Asia Cluster Head, Novartis

Miguel Angel Rivera Tapia

Global Digital Innovation Lead, Ferring Pharmaceuticals, Switzerland

How Ti-Hwei

Country President, AstraZeneca, Singapore

Bruce Shi

Chief Information Officer, Asia, Sanofi, Singapore

Amkidit Afable

Director Go-To-Market, Johnson & Johnson, Singapore

Aaron Tian

Head of Neuroscience Patient Innovation, UCB, China

Jean-Christophe Delumeau

Head of Pharmacovigilance Policy Strategy, Bayer, Singapore

Laurence Liew

Director, AI Singapore, Singapore

Prabhuram Krishnan

Medical Director (South Asia - Hong Kong, ASEAN, India), Ipsen, Singapore

Rafiqul Islam

IT Head-ADC Asia Pac, IT Business Relationship, Abbott Laboratories, Singapore

Jason Tamara Widjaja

Associate Director, Global Data Science (AI & Data Products), MSD, Singapore

Julie Olszewski

Executive Director, MSD Global Innovation Hub, MSD, Singapore

Paul Tan

Director, KPMG Healthcare & Life Sciences, Singapore

Yaron Turpaz

Chief Data & Technology Officer, Managing Director, Global Gene Corp, Singapore

Mrunalini Jagtap

Data Management Lead, Singapore Institute for Clinical Sciences, Agency for Science, Technology and Research, Singapore

Amit Singh

Director - Pharma Business, Elsevier, India

Dr. Dinesh Visva Gunaskeran

Steering Committee (Head, Big Data Protocol), Collaborative Ocular Tuberculosis Study, Singapore

Dr. Peter Ting

Co-Founder, Cardiatrics, Senior Consultant Cardiologist, Gleneagles and Mt. Elizabeth Hospital, Singapore

Tamsin Greulich-Smith

Chief, Smart Health Leadership Centre, Institute of Systems Science, National University of Singapore, Singapore

Winston Chew

Director, Regional Information Security Officer, GlaxoSmithKline, Singapore

Hazel Dy Tioco

Asia Pacific Regional Director, Study Management and Logistics, Sanofi, Philippines

Harish Dave

Co-Founder and Chief Medical Officer, Aum Biosciences, Singapore

開催期間と開催地

2018年9月19-20日

シンガポール、One Farrer Hotel & Spa
1 Farrer Park Station Road
Singapore 217562

Contact Person: Daniel Koh
DDI: (+65) 6705 7884
Fax: (+65) 6834 7892
Cell: (+65) 86870123
Email: danielkoh@onefarrer.com

スポンサー

パートナー